AHCO - AdaptHealth Corp Stock Price, Fair Value and News

$10.25+0.07 (+0.69%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

AHCO RSI Chart

AHCO Valuation

Market Cap

1.4B

Price/Earnings (Trailing)

-1.98

Price/Sales (Trailing)

0.42

EV/EBITDA

-14.97

Price/Free Cashflow

8.24

AHCO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AHCO Fundamentals

AHCO Revenue

Revenue (TTM)

3.3B

Rev. Growth (Yr)

1.6%

Rev. Growth (Qtr)

1.7%

AHCO Earnings

Earnings (TTM)

-690.7M

Earnings Growth (Yr)

39.05%

Earnings Growth (Qtr)

1.9K%

AHCO Price Action

Last 7 days

-9.4%

Last 30 days

-8.4%

Last 90 days

5.8%

Trailing 12 Months

27.4%

AHCO Profitability

EBT Margin

-22.26%

Return on Equity

-46.49%

Return on Assets

-15.31%

Free Cashflow Yield

12.14%

AHCO Financial Health

Current Ratio

1.15

Debt/Equity

1.37

Debt/Cashflow

0.25

AHCO Investor Care

Buy Backs (1Y)

1.20%

Diluted EPS (TTM)

-5.24

AHCO Alerts

2 major insider sales recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	3.2B	3.3B	0	0
2023	3.0B	3.1B	3.1B	3.2B
2022	2.7B	2.8B	2.9B	3.0B
2021	1.3B	1.7B	2.1B	2.5B
2020	601.6M	709.5M	857.5M	1.1B
2019	391.4M	437.5M	483.6M	529.6M
2018	0	0	0	345.3M

Get all data in R, Python etc through our Historical Stock Data APIs

About AdaptHealth Corp

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

WEBSITE	https://adapthealth.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	10900

AdaptHealth Corp Frequently Asked Questions

What is the ticker symbol for AdaptHealth Corp? What does AHCO stand for in stocks?

AHCO is the stock ticker symbol of AdaptHealth Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of AdaptHealth Corp (AHCO)?

As of Mon Oct 07 2024, market cap of AdaptHealth Corp is 1.37 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AHCO stock?

You can check AHCO's fair value in chart for subscribers.

Is AdaptHealth Corp a good stock to buy?

The fair value guage provides a quick view whether AHCO is over valued or under valued. Whether AdaptHealth Corp is cheap or expensive depends on the assumptions which impact AdaptHealth Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AHCO.

What is AdaptHealth Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Oct 07 2024, AHCO's PE ratio (Price to Earnings) is -1.98 and Price to Sales (PS) ratio is 0.42. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AHCO PE ratio will change depending on the future growth rate expectations of investors.